Company No:
Contents
| Note | 2025 | 2024 | ||
| £ | £ | |||
| Fixed assets | ||||
| Intangible assets | 3 |
|
|
|
| Tangible assets | 4 |
|
|
|
| Investments | 5 |
|
|
|
| 3,610,065 | 4,230,555 | |||
| Current assets | ||||
| Stocks |
|
|
||
| Debtors | ||||
| - due within one year | 6 |
|
|
|
| - due after more than one year | 6 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 2,108,160 | 1,723,005 | |||
| Creditors: amounts falling due within one year | 7 | (
|
(
|
|
| Net current liabilities | (7,953,393) | (11,608,295) | ||
| Total assets less current liabilities | (4,343,328) | (7,377,740) | ||
| Creditors: amounts falling due after more than one year | 8 | (
|
(
|
|
| Net liabilities | (
|
(
|
||
| Capital and reserves | ||||
| Called-up share capital | 9 |
|
|
|
| Profit and loss account | (
|
(
|
||
| Total shareholders' deficit | (
|
(
|
Directors' responsibilities:
The financial statements of Offshore Shellfish Limited (registered number:
|
John Michael Holmyard
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Offshore Shellfish Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is 21 Argyll Square, Oban, PA34 4AT, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
During the year to 30 April 2025, the Company generated a loss before tax of £360,157, and at 30 April 2025 had Net Liabilities of £9,077,208 and Net Current Liabilities of £7,953,393.
At 30 April 2025, unsecured loans plus accrued interest totalling £4,645,024 and preference shares treated as debt plus respective accrued dividends totalling £7,455,424, were due to the majority shareholder. The majority shareholder has agreed not to call in these balances, including the redeemable preference shares, for a period of at least 12 months from the date of approval of these accounts, to ensure that the Company can meet its financial obligations as they fall due.
At 30 April 2025, secured loans totalling £1,575,206, were due to a member of a corporate shareholder, who has agreed not to call in this balance for a period of at least 12 months from the date of approval of these accounts, to ensure that the Company can meet its financial obligations as they fall due.
The Directors are of the opinion that the Company will be able to pay its debts as they fall due, for a period of at least 12 months from the date of approval of these accounts, and accordingly confirm that it is correct for the accounts to be prepared on the going concern basis.
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.
Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Deferred research and development costs are reviewed annually, and where future benefits are deemed to have ceased or to be in doubt, the balance of any related research and development is written off to the Statement of Income and Retained Earnings.
The development expenditure on the mussel farm has been amortised from the commencement of commercial production, being 1 August 2018.
The estimated useful lives range as follows:
| Development costs |
|
| Leasehold improvements |
|
| Plant and machinery |
|
| Vehicles |
|
| Office equipment |
|
| Other property, plant and equipment |
|
|
|
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Non-financial assets
If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Financial assets
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
Dividends on shares recognised as liabilities are recognised as expenses and classified within interest payable.
| 2025 | 2024 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including directors |
|
|
| Development costs | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 May 2024 |
|
|
|
| At 30 April 2025 |
|
|
|
| Accumulated amortisation | |||
| At 01 May 2024 |
|
|
|
| Charge for the financial year |
|
|
|
| At 30 April 2025 |
|
|
|
| Net book value | |||
| At 30 April 2025 |
|
|
|
| At 30 April 2024 |
|
|
| Leasehold improve- ments |
Plant and machinery | Vehicles | Office equipment | Other property, plant and equipment |
Total | ||||||
| £ | £ | £ | £ | £ | £ | ||||||
| Cost | |||||||||||
| At 01 May 2024 |
|
|
|
|
|
|
|||||
| Additions |
|
|
|
|
|
|
|||||
| At 30 April 2025 |
|
|
|
|
|
|
|||||
| Accumulated depreciation | |||||||||||
| At 01 May 2024 |
|
|
|
|
|
|
|||||
| Charge for the financial year |
|
|
|
|
|
|
|||||
| At 30 April 2025 |
|
|
|
|
|
|
|||||
| Net book value | |||||||||||
| At 30 April 2025 | 192 | 1,518,230 | 19,500 | 13,071 | 1,106,893 | 2,657,886 | |||||
| At 30 April 2024 | 256 | 1,644,944 | 0 | 12,913 | 1,404,292 | 3,062,405 |
| Investments in joint ventures | Total | ||
| £ | £ | ||
| Cost or valuation before impairment | |||
| At 01 May 2024 |
|
|
|
| At 30 April 2025 |
|
|
|
| Carrying value at 30 April 2025 |
|
|
|
| Carrying value at 30 April 2024 |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Debtors: amounts falling due within one year | |||
| Trade debtors |
|
|
|
| Prepayments |
|
|
|
| VAT recoverable |
|
|
|
| Other debtors |
|
|
|
|
|
|
||
| Debtors: amounts falling due after more than one year | |||
| Other debtors |
|
|
| 2025 | 2024 | ||
| £ | £ | ||
| Bank loans |
|
|
|
| Trade creditors |
|
|
|
| Amounts owed to joint ventures |
|
|
|
| Amounts owed to directors |
|
|
|
| Other loans (secured £
|
|
|
|
| Accruals and deferred income |
|
|
|
| Other taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|
Also included in other loans is £4,645,024 (2024: £3,935,301) in respect of working capital loans provided by a Corporate Shareholder.
Other creditors includes £nil (2024: £4,007) of preference share capital and £nil (2024: £4,173,167) of preference share premium that has been treated as debt.
Included within accruals and deferred income is £3,278,250 (2024: £2,944,076) relating to accrued dividends on preference shares.
| 2025 | 2024 | ||
| £ | £ | ||
| Bank loans |
|
|
|
| Other loans |
|
|
|
| Deferred income |
|
|
|
| Other creditors |
|
|
|
|
|
|
Other loans in the prior year relate to working capital loans provided by a Corporate Shareholder.
Other creditors includes £4,007 (2024: £nil) of preference share capital and £4,173,167 (2024: £nil) of preference share premium that has been treated as debt.
| 2025 | 2024 | ||
| £ | £ | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4,007 | 4,007 | ||
| 5,007 | 5,007 |
Commitments
Total future minimum lease payments under non-cancellable operating leases are as follows:
| 2025 | 2024 | ||
| £ | £ | ||
| within one year |
|
|
|
| between one and five years |
|
|
|
| after five years |
|
|
|
| Total future minimum lease payments under non-cancellable operating leases |
|
|
Pensions
The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.
| 2025 | 2024 | ||
| £ | £ | ||
| Unpaid contributions due to the fund (inc. in other creditors) |
|
|
Contingent assets
| 2025 | 2024 | ||
| £ | £ | ||
| Total contingent assets |
|
|
Transactions with the entity's directors
| 2025 | 2024 | ||
| £ | £ | ||
| Amounts owed to a shareholder director | 33,042 | 33,660 |
Remuneration of £120,684 (2024: £115,438) was paid to the shareholder director.
Other related party transactions
| 2025 | 2024 | ||
| £ | £ | ||
| Amounts owed to a corporate shareholder | 12,087,758 | 11,569,436 | |
| Amounts owed to a shareholder | 12,689 | 12,115 | |
| Amounts owed to a member of the corporate shareholder | 1,575,206 | 1,583,305 |
At the year end, a corporate shareholder was owed £12,087,758 (2024: £11,569,436) from the Company, broken down as follows:
- Loan capital: £3,663,247 (2024: £3,663,247)
- Accrued loan interest: £981,778 (2024: £797,055)
- Preference share capital: £4,000 (2024: £4,000)
- Preference share premium: £4,166,000 (2024: £4,166,000)
- Accrued preference share dividends: £ 3,272,735 (2024: £2,939,134)
During the year, loan interest of £184,723 (2024: £177,458) was charged in respect of four separate loans, accruing interest at different rates of; 5% over the London Interbank Offered Rate, 6% over the London Interbank Offered Rate, and 3% over the Barclays base rate.
At the year end, a member of a corporate shareholder was owed £1,575,206 (2024: £1,583,305) from the Company in respect of a boat mortgage. Interest at 4.5% above the European Interbank Offered Rate was charged and paid over during the year, totalling £108,975 (2024: £122,339).
At the year end, a shareholder was owed £12,689 (2024: £12,115) in respect of the following:
- Preference share capital: £7 (2024: £7)
- Preference share premium: £7,167 (2024: £7,167)
- Accrued preference share dividends: £5,515 (2024: £4,941)
During 2022, the Company invested in a joint venture, being a Dutch Partnership, at a cost of £250,274. During the current year, the Company made sales of £2,990,341 (2024: £1,203,345) to the joint venture, and £87,892 (2024: £nil) relating to these sales was owed to the Company at the year end.
The Company's profit share from the joint venture for the year was £43,844 (2024: £68,718) and has been recognised in income from participating interests. At the year end, the Company owed £117,956 to the joint venture (2024: £181,556).